Sensitizing to apoptosis - sharpening the medical sword

被引：21

作者：

Schuchmann, M ^{[1
]}

Galle, PR ^{[1
]}

机构：

[1] Univ Mainz, Dept Internal Med 1, D-55131 Mainz, Germany

来源：

JOURNAL OF HEPATOLOGY | 2004年 / 40卷 / 02期

关键词：

D O I：

10.1016/j.jhep.2003.11.022

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：335 / 336

页数：2

共 20 条

[1]

Allgaier HP, 2003, HEPATOLOGY, V38, p760A

[2] Histone acetylation and cancer [J].

Archer, SY ;

Hodin, RA .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (02) :171-174

[3] Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts [J].

Bernhard, D ;

Skvortsov, S ;

Tinhofer, I ;

Hübl, H ;

Greil, R ;

Csordas, A ;

Kofler, R .

CELL DEATH AND DIFFERENTIATION, 2001, 8 (10) :1014-1021

[4] Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate [J].

Bonnotte, B ;

Favre, N ;

Reveneau, S ;

Micheau, O ;

Droin, N ;

Garrido, C ;

Fontana, A ;

Chauffert, B ;

Solary, E ;

Martin, F .

CELL DEATH AND DIFFERENTIATION, 1998, 5 (06) :480-487

[5] NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma [J].

Catley, L ;

Weisberg, E ;

Tai, YT ;

Atadja, P ;

Remiszewski, S ;

Hideshima, T ;

Mitsiades, N ;

Shringarpure, R ;

LeBlanc, R ;

Chauhan, D ;

Munshi, NC ;

Schlossman, R ;

Richardson, P ;

Griffin, J ;

Anderson, KC .

BLOOD, 2003, 102 (07) :2615-2622

[6]

Glaser KB, 2002, MOL CANCER THER, V1, P759

[7] BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].

HOCKENBERY, D ;

NUNEZ, G ;

MILLIMAN, C ;

SCHREIBER, RD ;

KORSMEYER, SJ .

NATURE, 1990, 348 (6299) :334-336

[8]

Inoue H, 2002, INT J MOL MED, V9, P521

[9]

Kelly WK, 2003, CLIN CANCER RES, V9, P3578

[10]

Kouraklis G., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P477, DOI 10.2174/1568011023353921

← 1 2 →